A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-beta2-induced ECM expression. Zhang R, Li N, Fan Y, Qing D, et al. Exp Eye Res 2025;256:110386.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang R, Li N, Fan Y, Qing D, et al. A multi-omics study reveals molecular characteristics and therapeutic targets of salidroside in reducing TGF-beta2-induced ECM expression. Exp Eye Res 2025;256:110386.
PMID: 40216062